While the first monoclonal antibody was approved for therapeutic use by the FDA way back in 1986, don’t imply to Mondher Mahjoubi, M.D., that they’re old hat, cookie-cutter, or easy. I almost made that mistake when I suggested to him that several conversations I’ve had with the leaders of antibody therapeutics companies would lead me […]

DarioHealth (Nasdaq:DRIO) today announced real-world study data on the impact of managing diabetes and weight on a single digital platform. New York-based DarioHealth presented the published retrospective, real-world study observing its digital therapeutics platform at the Advanced Technologies and Treatments for Diabetes (ATTD) Conference in Barcelona.

Cytovia Therapeutics has found an “ISLE” to dock at in the choppy waters of biotech public markets. The natural killer (NK) cell startup is set to merge with a special purpose acquisition company (SPAC) to secure the cash to enter the clinic and try to get through to a data drop in 2024. Isleworth Healthcare Acquisition Corp. […]